{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:21:41Z","timestamp":1782926501533,"version":"3.54.5"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a chronic liver condition closely associated with metabolic syndrome, with its incidence rate continuously rising globally. Recent studies have shown that the development of NAFLD is associated with insulin resistance, lipid metabolism disorder, oxidative stress and endoplasmic reticulum stress. Therapeutic strategies for NAFLD include lifestyle modifications, pharmacological treatments, and emerging biological therapies; however, there is currently no specific drug to treat NAFLD. However Chinese herb medicine (CHM) has shown potential in the treatment of NAFLD due to its unique therapeutic concepts and methods for centuries in China. This review aims to summarize the pathogenesis of NAFLD and some CHMs that have been shown to have therapeutic effects on NAFLD, thus enriching the scientific connotation of TCM theories and facilitating the exploration of TCM in the treatment of NAFLD.<\/jats:p>","DOI":"10.3389\/fphar.2024.1499602","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:11:06Z","timestamp":1731474666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuqiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: past, present, future","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytother. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hep.32562","article-title":"Endoplasmic reticulum stress in liver diseases","volume":"77","author":"Ajoolabady","year":"2023","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","article-title":"Lipid disorders and metabolic-associated fatty liver disease","volume":"52","author":"Anwar","year":"2023","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/food.200390045","article-title":"Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts","volume":"47","author":"Bahorun","year":"2003","journal-title":"Nahrung"},{"key":"B5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/pca.1267","article-title":"Comparing the composition and bioactivity of Crataegus Monogyna flowers and fruits used in folk medicine","volume":"22","author":"Barros","year":"2011","journal-title":"Phytochem. Anal."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-021-00559-3","article-title":"Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages","volume":"17","author":"Cao","year":"","journal-title":"Chin. Med."},{"key":"B10","first-page":"2195","article-title":"Study on the mechanism of Huazhi Rougan Granules in alleviating non-alcoholic steatohepatitis by inhibiting endoplasmic reticulum stress","volume":"39","author":"Cao","year":"2024","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"858795","DOI":"10.3389\/fphar.2022.858795","article-title":"Multi-omics integration analysis identifies lipid disorder of a non-alcoholic fatty liver disease (NAFLD) mouse model improved by zexie-baizhu decoction","volume":"13","author":"Cao","year":"","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"112825","DOI":"10.1016\/j.biopha.2022.112825","article-title":"Jiangzhi granule attenuates non-alcoholic steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet","volume":"149","author":"Cao","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.3390\/ijms222111383","article-title":"The ameliorative effects of Saikosaponin in thioacetamide-induced liver injury and non-alcoholic fatty liver disease in mice","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1343755","DOI":"10.3389\/fphar.2024.1343755","article-title":"Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"116199","DOI":"10.1016\/j.jep.2023.116199","article-title":"Cassiae Semen: a comprehensive review of botany, traditional use, phytochemistry, pharmacology, toxicity, and quality control","volume":"306","author":"Chen","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"154752","DOI":"10.1016\/j.metabol.2021.154752","article-title":"Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes","volume":"121","author":"Ciardullo","year":"2021","journal-title":"Metabolism"},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jep.2017.06.030","article-title":"Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation","volume":"208","author":"Cui","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/m15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann. Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: a translational approach","volume":"16","author":"Dai","year":"2022","journal-title":"Front. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"109976","DOI":"10.1016\/j.biopha.2020.109976","article-title":"Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"387626","DOI":"10.1155\/2012\/387626","article-title":"Mitochondrial roles and cytoprotection in chronic liver injury","volume":"2012","author":"Degli Esposti","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.febslet.2007.07.084","article-title":"Role of ChREBP in hepatic steatosis and insulin resistance","volume":"582","author":"Denechaud","year":"2008","journal-title":"FEBS Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.3390\/molecules24213943","article-title":"Lipidomic analysis of the protective effects of shenling Baizhu san on non-alcoholic fatty liver disease in rats","volume":"24","author":"Deng","year":"2019","journal-title":"Molecules"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"28734","DOI":"10.1038\/srep28734","article-title":"New insights into salvianolic acid A action: regulation of the TXNIP\/NLRP3 and TXNIP\/ChREBP pathways ameliorates HFD-induced NAFLD in rats","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chmed.2022.09.006","article-title":"Cassiae Semen improves non-alcoholic fatty liver disease through autophagy-related pathway","volume":"15","author":"Ding","year":"2023","journal-title":"Chin. Herb. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/jci23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberl\u00e9","year":"2004","journal-title":"Biochimie"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2174\/0929867324666170426142826","article-title":"Divergent roles of IRS (insulin receptor substrate) 1 and 2 in liver and skeletal muscle","volume":"24","author":"Eckstein","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/1735-1995.193178","article-title":"Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial","volume":"21","author":"Ekhlasi","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.tem.2019.07.013","article-title":"Are lifestyle therapies effective for NAFLD treatment?","volume":"30","author":"El-Agroudy","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s1875-5364(23)60403-0","article-title":"Therapeutic potential of alkaloid extract from Codonopsis Radix in alleviating hepatic lipid accumulation: insights into mitochondrial energy metabolism and endoplasmic reticulum stress regulation in NAFLD mice","volume":"21","author":"Fan","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jgh.12244","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","author":"Fan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOL.0b013e3283395e5c","article-title":"Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis","volume":"21","author":"Flamment","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/circresaha.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","article-title":"The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"155313","DOI":"10.1016\/j.phymed.2023.155313","article-title":"Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia","volume":"128","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/ars.2010.3790","article-title":"Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease","volume":"15","author":"Gentile","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1111\/j.1749-6632.2009.04956.x","article-title":"From sugar to fat: how the transcription factor XBP1 regulates hepatic lipogenesis","volume":"1173","author":"Glimcher","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.3748\/wjg.v22.i27.6318","article-title":"Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review","volume":"22","author":"Golabi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B1600043","article-title":"Molecular signal networks and regulating mechanisms of the unfolded protein response","volume":"18","author":"Gong","year":"2017","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.6039\/j.issn.1001-0408.2017.34.06","article-title":"Study on the hepatoprotective effects of hugan tablets based on serum and liver metabonomics","volume":"28","author":"Gong","year":"2017","journal-title":"China Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"154219","DOI":"10.1016\/j.phymed.2022.154219","article-title":"Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPAR\u03b1 and INSIG\/SREBP1c pathway","volume":"103","author":"Gu","year":"2022","journal-title":"Phytomedicine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"584","DOI":"10.11669\/cpj.2023.07.005","article-title":"Study on the protective effect and mechanism of compound yiganling on nonalcoholic fatty liver based on network pharmacology and zebrafish model","volume":"58","author":"Guo","year":"2023","journal-title":"Chin. Pharm. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"122","DOI":"10.19852\/j.cnki.jtcm.20231215.001","article-title":"Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification","volume":"44","author":"Guoguo","year":"2024","journal-title":"J. Tradit. Chin. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"153544","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine Stuttg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/fjc.0000000000000373","article-title":"Saikosaponin-a attenuates oxidized LDL uptake and prompts cholesterol efflux in THP-1 cells","volume":"67","author":"He","year":"2016","journal-title":"J. Cardiovasc Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1111\/jcmm.14380","article-title":"Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK\/ACC\/SREBP-1c pathway","volume":"23","author":"Ho","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/ijms18030620","article-title":"A biomedical investigation of the hepatoprotective effect of radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets","volume":"18","author":"Hong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"529553","DOI":"10.3389\/fphar.2020.529553","article-title":"The target MicroRNAs and potential underlying mechanisms of yiqi-bushen-tiaozhi recipe against-non-alcoholic steatohepatitis","volume":"11","author":"Hong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1073\/pnas.0401516101","article-title":"Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis","volume":"101","author":"Iizuka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1507\/endocrj.k07e-110","article-title":"ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome","volume":"55","author":"Iizuka","year":"2008","journal-title":"Endocr. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/mol.0000000000000080","article-title":"Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans","volume":"25","author":"Jacome-Sosa","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/s0168-8278(98)80073-1","article-title":"Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance","volume":"29","author":"James","year":"1998","journal-title":"J. Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.3892\/mmr.2016.5133","article-title":"Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2\/Pcsk9 signaling pathway in hyperlipidemic rats","volume":"13","author":"Jia","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"154326","DOI":"10.1016\/j.phymed.2022.154326","article-title":"Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease","volume":"104","author":"Jia","year":"2022","journal-title":"J. Artic. Phytomedicine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"908128","DOI":"10.3389\/fphar.2022.908128","article-title":"Protective effects and mechanisms of yinchen linggui zhugan decoction in HFD-induced nonalcoholic fatty liver disease rats based on network pharmacology and experimental verification","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11655-016-2252-4","article-title":"Protective effects of Chaihu shugan san on nonalcoholic fatty liver disease in rats with insulin resistance","volume":"24","author":"Jiang","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/eci.13622","article-title":"Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship","volume":"52","author":"Karkucinska-Wieckowska","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","article-title":"Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls","volume":"13","author":"Kaufman","year":"1999","journal-title":"Genes Dev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nrd2755","article-title":"Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities","volume":"7","author":"Kim","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1172\/jci81993","article-title":"ChREBP regulates fructose-induced glucose production independently of insulin signaling","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1021\/jf030096r","article-title":"Antioxidant capacity of polyphenolic extracts from leaves of Crataegus laevigata and Crataegus monogyna (Hawthorn) subjected to drought and cold stress","volume":"51","author":"Kirakosyan","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3892\/ijmm.20.3.351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B78","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13020-021-00434-1","article-title":"Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat","volume":"16","author":"Lan Q.","year":"2021","journal-title":"Chin. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1749-8546-9-21","article-title":"Autophagic effects of Chaihu (dried roots of Bupleurum chinense DC or Bupleurum scorzoneraefolium WILD)","volume":"9","author":"Law","year":"2014","journal-title":"Chin. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"967623","DOI":"10.3389\/fphar.2022.967623","article-title":"Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: a network pharmacology study and in vivo experimental validation","volume":"13","author":"Lei","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"153135","DOI":"10.1016\/j.phymed.2019.153135","article-title":"Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway","volume":"66","author":"Leng","year":"2020","journal-title":"Phytomedicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"173264","DOI":"10.1016\/j.ejphar.2020.173264","article-title":"Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation","volume":"882","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"833414","DOI":"10.3389\/fphar.2022.833414","article-title":"Medicinal formula huazhi-rougan attenuates non-alcoholic steatohepatitis through enhancing fecal bile acid excretion in mice","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.fitote.2012.05.009","article-title":"Study on the hypoglycemic activities and metabolism of alcohol extract of Alismatis Rhizoma","volume":"83","author":"Li","year":"2012","journal-title":"Fitoterapia"},{"key":"B86","doi-asserted-by":"publisher","first-page":"560905","DOI":"10.3389\/fphar.2020.560905","article-title":"Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1007\/s00253-020-10614-y","article-title":"Crosstalk between ER stress, NLRP3 inflammasome, and inflammation","volume":"104","author":"Li","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phymed.2018.09.174","article-title":"A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins","volume":"50","author":"Li","year":"2018","journal-title":"Phytomedicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"106","DOI":"10.12025\/j.issn.1008-6358.2021.20200155","article-title":"Therapeutic effect analysis of rhubaric acid on non-alcoholic fatty liver disease in mice","volume":"28","author":"Lin","year":"2021","journal-title":"Chin. J. Clin. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.jep.2022.115382","article-title":"Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo","volume":"295","author":"Liu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"875700","DOI":"10.3389\/fphar.2022.875700","article-title":"Revealing the mechanism of huazhi rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jgr.2018.10.005","article-title":"Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice","volume":"44","author":"Lu","year":"2020","journal-title":"J. Ginseng Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"984019","DOI":"10.3389\/fmicb.2022.984019","article-title":"Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s42003-021-02883-8","article-title":"Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota","volume":"4","author":"Luo","year":"2021","journal-title":"Commun. Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"12956","DOI":"10.3748\/wjg.v20.i36.12956","article-title":"Non-alcoholic fatty liver disease: what the clinician needs to know","volume":"20","author":"Machado","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/aps.2016.119","article-title":"Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B99","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/13880209.2019.1568509","article-title":"Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat","volume":"57","author":"Meng","year":"2019","journal-title":"Pharm. Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"B101","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"B102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr. Berl."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1272214","DOI":"10.3389\/fendo.2023.1272214","article-title":"Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids","volume":"14","author":"Ni","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"155712","DOI":"10.1016\/j.phymed.2024.155712","article-title":"Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats","volume":"130","author":"Pan","year":"2024","journal-title":"Phytomedicine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.joim.2021.07.004","article-title":"Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4\/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease","volume":"19","author":"Pan","year":"2021","journal-title":"J. Integr. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.2099","article-title":"The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation","volume":"16","author":"Park","year":"2010","journal-title":"Nat. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"G193","DOI":"10.1152\/ajpgi.00426.2001","article-title":"Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis","volume":"282","author":"Pessayre","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/dom.12989","article-title":"Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"19","author":"Polyzos","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"B113","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/jci34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest"},{"key":"B115","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"155691","DOI":"10.1016\/j.phymed.2024.155691","article-title":"Compound Shouwu Jiangzhi Granule regulates triacylglyceride synthesis to alleviate hepatic lipid accumulation","volume":"129","author":"Qian","year":"2024","journal-title":"Phytomedicine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"545","DOI":"10.13193\/j.archtcm.2013.03.99.cenbch.054","article-title":"Effect of rhubaric acid on prevention and treatment of nonalcoholic fatty liver disease induced by high fat diet in rats","volume":"31","author":"Qin","year":"2013","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"153140","DOI":"10.1016\/j.phymed.2019.153140","article-title":"Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2\/HO-1 antioxidant signaling pathway","volume":"67","author":"Qiu","year":"2020","journal-title":"Phytomedicine"},{"key":"B119","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1080\/07391102.2023.2231544","article-title":"Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and in vivo experiments","volume":"42","author":"Ruan","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B120","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb Philos. Soc."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/s1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3748\/wjg.14.2474","article-title":"Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment","volume":"14","author":"Schreuder","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1124\/dmd.111.040212","article-title":"Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C","volume":"39","author":"Schrieber","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"B125","doi-asserted-by":"publisher","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism","volume":"281","author":"Schweiger","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Investig."},{"key":"B127","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"155183","DOI":"10.1016\/j.phymed.2023.155183","article-title":"Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1","volume":"123","author":"Shang","year":"2024","journal-title":"Phytomedicine"},{"key":"B129","doi-asserted-by":"publisher","first-page":"944088","DOI":"10.3389\/fphar.2022.944088","article-title":"The pathogenesis of HCC driven by NASH and the preventive and therapeutic effects of natural products","volume":"13","author":"Shao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1080\/15384101.2020.1829800","article-title":"Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS\/TLR4 signaling pathway","volume":"19","author":"Shen","year":"2020","journal-title":"Cell Cycle"},{"key":"B131","doi-asserted-by":"publisher","first-page":"E886","DOI":"10.1152\/ajpendo.00332.2010","article-title":"Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice","volume":"300","author":"Sheng","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B132","doi-asserted-by":"publisher","first-page":"115477","DOI":"10.1016\/j.jep.2022.115477","article-title":"Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation","volume":"296","author":"Shi","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"108676","DOI":"10.1016\/j.biopha.2019.108676","article-title":"Preventive and therapeutic role of Tanshinone \u2161A in hepatology","volume":"112","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8749564","DOI":"10.1155\/2020\/8749564","article-title":"Nonalcoholic fatty liver disease: pathogenesis and treatment in traditional Chinese medicine and western medicine","volume":"2020","author":"Shi","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12906-019-2811-2","article-title":"Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1\/CRTC2 signaling in experimental diabetic rats","volume":"20","author":"Song","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"B136","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of Fatty liver","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr. Rev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile acids and FXR: novel targets for liver diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"7700","DOI":"10.1021\/jf801668c","article-title":"Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract","volume":"56","author":"Tadi\u0107","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"116418","DOI":"10.1016\/j.jep.2023.116418","article-title":"Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease","volume":"310","author":"Tan","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/ph17040502","article-title":"Effects of ganjianglingzhu decoction on lean non-alcoholic fatty liver disease in mice based on untargeted metabolomics","volume":"17","author":"Tang","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"B141","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.celrep.2017.05.035","article-title":"Hepatic diacylglycerol-associated protein kinase c\u03b5 translocation links hepatic steatosis to hepatic insulin resistance in humans","volume":"19","author":"Ter Horst","year":"2017","journal-title":"Cell Rep."},{"key":"B143","doi-asserted-by":"publisher","first-page":"115806","DOI":"10.1016\/j.jep.2022.115806","article-title":"Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose","volume":"301","author":"Tian","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12933-018-0738-4","article-title":"Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy","volume":"17","author":"van Stee","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12944-022-01689-9","article-title":"Danshao Shugan Granule therapy for non-alcoholic fatty liver disease","volume":"21","author":"Wang","year":"2022","journal-title":"Lipids Health Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e0143625","DOI":"10.1371\/journal.pone.0143625","article-title":"A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"10104","DOI":"10.3748\/wjg.v21.i35.10104","article-title":"Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nm.2121","article-title":"A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response","volume":"16","author":"Winnay","year":"2010","journal-title":"Nat. Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbi.2018.06.005","article-title":"Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK\/mTOR pathway","volume":"291","author":"Wu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.14218\/JCTH.2021.00458","article-title":"Quzhi formula alleviates nonalcoholic steatohepatitis by impairing hepatocyte lipid accumulation and inflammation via bip\/eIF2\u03b1 signaling","volume":"10","author":"Wu","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1875-5364(19)30010-x","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"MEIm","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"940","DOI":"10.19852\/j.cnki.jtcm.2022.06.007","article-title":"Effect of Dangfei Liganning capsule on liver X receptor \u03b1\/steroid regulatory element binding protein-1\/fatty acid synthase signal pathway in rats with metabolic-associated fatty liver disease","volume":"42","author":"Xiaoling","year":"2022","journal-title":"J. Traditional Chin. Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e22151","DOI":"10.1016\/j.heliyon.2023.e22151","article-title":"Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"key":"B155","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jtcme.2023.02.010","article-title":"Yinchenhao Tang alleviates high fat diet induced NAFLD by increasing NR1H4 and APOA1 expression","volume":"13","author":"Xu","year":"2023","journal-title":"J. Tradit. Complement. Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"115999","DOI":"10.1016\/j.jep.2022.115999","article-title":"Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4\/NF-\u03baB\/NLRP3 pathway","volume":"303","author":"Yan","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.3892\/etm.2017.5162","article-title":"Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver","volume":"14","author":"Yang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2174\/0118715303257018230927182802","article-title":"Huangqin-huanglian decoction protects liver against non-alcoholic fatty liver disease in high fat-diet mice","volume":"24","author":"Yang","year":"2024","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B159","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.3748\/wjg.v25.i34.5105","article-title":"Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease","volume":"25","author":"Yang","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jep.2014.04.011","article-title":"Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPAR\u03b1 pathways in L02 cells and HepG2 cells","volume":"154","author":"Yin","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/nu8050283","article-title":"Hawthorn fruit extract elevates expression of Nrf2\/HO-1 and improves lipid profiles in ovariectomized rats","volume":"8","author":"Yoo","year":"2016","journal-title":"Nutrients"},{"key":"B163","doi-asserted-by":"publisher","first-page":"118165","DOI":"10.1016\/j.jep.2024.118165","article-title":"Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways","volume":"329","author":"You","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"172715","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/sj.emboj.7600106","article-title":"ATF6 modulates SREBP2-mediated lipogenesis","volume":"23","author":"Zeng","year":"2004","journal-title":"Embo J."},{"key":"B168","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/srep16013","article-title":"Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci. Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.2147\/DMSO.S332659","article-title":"QSHY granules promote white adipose tissue browning and correct BCAAs metabolic disorder in NAFLD mice","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B170","doi-asserted-by":"publisher","first-page":"3413186","DOI":"10.1155\/2020\/3413186","article-title":"Kangtaizhi granule alleviated nonalcoholic fatty liver disease in high-fat diet-fed rats and HepG2 cells via AMPK\/mTOR signaling pathway","volume":"2020","author":"Zhang","year":"2020","journal-title":"J. Immunol. Res."},{"key":"B171","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"B172","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.1016\/j.redox.2019.101284","article-title":"Biochemical basis and metabolic interplay of redox regulation","volume":"26","author":"Zhang","year":"2019","journal-title":"Redox Biol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.13381","article-title":"Therapeutic potential of Rhizoma Alismatis: a review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology","volume":"1401","author":"Zhang","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180644","article-title":"The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPK\u03b1","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"key":"B175","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3724\/abbs.2024025","article-title":"Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1\/FOXM1 pathway-dependent lipid synthesis","volume":"56","author":"Zhang","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3969\/j.issn.1001-5256.2017.12.002","article-title":"Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)","volume":"33","author":"Zhang","year":"2017","journal-title":"J. Clin. Hepatobiliary Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/s0955-2863(00)00137-6","article-title":"Characterization of antioxidants present in hawthorn fruits","volume":"12","author":"Zhang","year":"2001","journal-title":"J. Nutr. Biochem."},{"key":"B178","doi-asserted-by":"publisher","first-page":"605","DOI":"10.16680\/j.1671-3826.2018.06.01","article-title":"Effect of Xuezhikang on hepatitis and oxidative stress in rats with nonalcoholic fatty liver disease","volume":"46","author":"Zhang","year":"2018","journal-title":"Clin. J. Med. Officers"},{"key":"B179","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3969\/j.issn.1671-038X.2014.09.04","article-title":"Experimental study of Kezhi capsule on PPAR-\u03b3and IR expression in non-alcoholic steatohepatitis rats","volume":"22","author":"Zhao","year":"2014","journal-title":"Chin. J. Integr. Traditional West. Med. Dig."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/nu14122411","article-title":"Alisol B alleviates hepatocyte lipid accumulation and lipotoxicity via regulating rar\u03b1-ppar\u03b3-CD36 cascade and attenuates non-alcoholic steatohepatitis in mice","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"B181","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3967\/bes2018.059","article-title":"Association between IgG N-glycans and nonalcoholic fatty liver disease in han Chinese","volume":"31","author":"Zhao","year":"2018","journal-title":"Biomed. Environ. Sci."},{"key":"B182","doi-asserted-by":"publisher","first-page":"116967","DOI":"10.1016\/j.jep.2023.116967","article-title":"Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis","volume":"318","author":"Zheng","year":"2024","journal-title":"J. Ethnopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1499602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:11:23Z","timestamp":1731474683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1499602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":182,"alternative-id":["10.3389\/fphar.2024.1499602"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1499602","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"article-number":"1499602"}}